Keith Wan
Optometrist · San Diego, CANPI 1235181165
Payments from drug & device makers
Across 344 payments — averaging $2578.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon Research LLC$651K
- Johnson & Johnson Vision Care, Inc.$124K
- Coopervision Inc.$77K
- Oyster Point Pharma, Inc.$21K
- Tarsus Pharmaceuticals, Inc.$8K
- Alcon$3K
- plus $3K from 11 others
Across 1 payment — averaging $22,260 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Coopervision Inc.$22K
What the payments were for
- Consulting fees$17,44020%
- Speaking & faculty fees$46,92754%
- Travel & lodging$12,38914%
- Food & beverage$9,92511%
- Education$5001%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon Research LLC | 58 | $651,004 |
| Johnson & Johnson Vision Care, Inc. | 29 | $124,140 |
| Coopervision Inc. | 156 | $77,120 |
| Oyster Point Pharma, Inc. | 3 | $20,602 |
| Tarsus Pharmaceuticals, Inc. | 12 | $8,142 |
| Alcon | 45 | $3,166 |
| Bausch & Lomb Americas Inc. | 14 | $1,441 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 7 | $383 |
| Biotissue Holdings Inc. | 6 | $338 |
| Topcon Healthcare, Inc. | 1 | $300 |
| Regeneron Healthcare Solutions, Inc. | 1 | $120 |
| Ocular Therapeutix, Inc. | 3 | $88 |
| Sight Sciences, Inc. | 4 | $69 |
| Genentech USA, Inc. | 1 | $59 |
| AbbVie(2 entities) | 2 | $35 |
| Eyevance Pharmaceuticals LLC | 1 | $24 |
| Kala Pharmaceuticals, Inc. | 1 | $23 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MiSight Contact Lens$61,772
- MyDay Contact Lens$8,190
- INFUSE$1,132
- TOTAL30$395
- MIEBO$276
- Prokera$247
- AmnioGraft$247
- LOTEMAX SM$234
- VYZULTA$150
- Precision7$133
- XIIDRA$126
- Acuvue$125
- XDEMVY$122
- EYLEA$120
- Multiple Brands Contact Lens$100
How this compares
$887,055 in reported general payments places this provider in the 95th percentile of 6,778 optometrist providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other optometrist in San Diego
- David GeffenSan Diego$384K
- Jason TuSan Diego$351K
- Dorothy WangSan Diego$312K
- Alicia LauSan Diego$300K
- Melody TavakoliSan Diego$267K
- Brian ChouSan Diego$243K
- Eric WhiteSan Diego$211K
- Elliott ShapiroSan Diego$135K
- Brittany McMurrenSan Diego$80K
- Meng LinBerkeley$6.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.